Biosketch / Results /

Irene Barbazetto

Clinical Instructor, Department of Ophthalmology

Contact Info

Address
462 First Avenue
New York, NY 10016

212/861-9797


Risk Alleles Associated with Neovascularization in a Pachychoroid Phenotype
Dansingani, Kunal K; Perlee, Lorah T; Hamon, Sara; Lee, May; Shah, Vinnie P; Spaide, Richard F; Sorenson, John; Klancnik, James M Jr; Yannuzzi, Lawrence A; Barbazetto, Irene A; Cooney, Michael J; Engelbert, Michael; Chen, Christine; Hewitt, Alex W; Freund, K Bailey. Risk Alleles Associated with Neovascularization in a Pachychoroid Phenotype. Ophthalmology. 2016 Dec;123(12):2628-2630 (2255162)

Bullous Variant of Central Serous Chorioretinopathy: Expansion of Phenotypic Features Using Multimethod Imaging
Balaratnasingam, Chandrakumar; Freund, K Bailey; Tan, Anna M; Mrejen, Sarah; Hunyor, Alex P; Keegan, David J; Dansingani, Kunal K; Dayani, Pouya N; Barbazetto, Irene A; Sarraf, David; Jampol, Lee M; Yannuzzi, Lawrence A. Bullous Variant of Central Serous Chorioretinopathy: Expansion of Phenotypic Features Using Multimethod Imaging. Ophthalmology. 2016 Jul;123(7):1541-1552 (2078552)

Multimodal Imaging in Handheld Laser-Induced Maculopathy
Bhavsar, Kavita V; Wilson, Deanna; Margolis, Ron; Judson, Peter; Barbazetto, Irene; Freund, K Bailey; Cunningham, Emmett T Jr. Multimodal Imaging in Handheld Laser-Induced Maculopathy. American journal of ophthalmology. 2015 Feb;159(2):227-31.e2 (1370432)

Long-term anatomical and functional outcomes after switch to aflibercept therapy for neovascular age-related macular degeneration
Chae, Bora; Barbazetto, Irene; Gallego-Pinazo, Roberto; Patel, Samir. Long-term anatomical and functional outcomes after switch to aflibercept therapy for neovascular age-related macular degeneration [Meeting Abstract]. Investigative ophthalmology & visual science. IOVS. 2015 JUN;56(7):?-? (1839222)

Reduced effect of anti-vascular endothelial growth factor agents on diabetics with vitreomacular interface abnormalities
Yoon, Dan; Rusu, Irene; Barbazetto, Irene. Reduced effect of anti-vascular endothelial growth factor agents on diabetics with vitreomacular interface abnormalities. International ophthalmology. 2014 Aug;34(4):817-823 (811992)